Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptor, Cannabinoid, CB1 | 28 | 2017 | 51 | 7.050 |
Why?
|
Receptors, Cannabinoid | 11 | 2011 | 26 | 1.870 |
Why?
|
Endocannabinoids | 12 | 2016 | 34 | 1.790 |
Why?
|
Carrier Proteins | 6 | 2017 | 131 | 1.780 |
Why?
|
Signal Transduction | 20 | 2017 | 666 | 1.700 |
Why?
|
Fibroblasts | 3 | 2015 | 103 | 1.410 |
Why?
|
Cannabinoids | 12 | 2016 | 39 | 1.410 |
Why?
|
Receptor, Cannabinoid, CB2 | 6 | 2017 | 16 | 1.250 |
Why?
|
Cyclic AMP | 5 | 2016 | 40 | 1.220 |
Why?
|
Animals | 41 | 2017 | 7297 | 1.180 |
Why?
|
GTP-Binding Proteins | 5 | 2016 | 24 | 1.130 |
Why?
|
Naphthalenes | 11 | 2016 | 39 | 0.910 |
Why?
|
Arachidonic Acids | 7 | 2015 | 23 | 0.860 |
Why?
|
Receptors, Dopamine D2 | 6 | 2016 | 80 | 0.850 |
Why?
|
Mice | 17 | 2017 | 2368 | 0.800 |
Why?
|
Morpholines | 9 | 2016 | 34 | 0.790 |
Why?
|
Cell Line, Tumor | 10 | 2017 | 680 | 0.790 |
Why?
|
Gene Expression Regulation | 4 | 2015 | 481 | 0.770 |
Why?
|
Neurons | 5 | 2015 | 394 | 0.740 |
Why?
|
Gene Expression | 4 | 2013 | 332 | 0.720 |
Why?
|
Receptors, Drug | 4 | 2002 | 14 | 0.720 |
Why?
|
Pyrazoles | 8 | 2016 | 64 | 0.670 |
Why?
|
Piperidines | 9 | 2016 | 125 | 0.660 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2017 | 24 | 0.650 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2017 | 2 | 0.620 |
Why?
|
Nitric Oxide | 5 | 2014 | 116 | 0.620 |
Why?
|
Polyunsaturated Alkamides | 6 | 2014 | 9 | 0.610 |
Why?
|
Antibodies | 1 | 2017 | 53 | 0.610 |
Why?
|
Benzoxazines | 9 | 2016 | 20 | 0.590 |
Why?
|
Phosphorylation | 8 | 2016 | 225 | 0.560 |
Why?
|
Baclofen | 2 | 2015 | 12 | 0.550 |
Why?
|
Corpus Striatum | 3 | 2014 | 60 | 0.540 |
Why?
|
Skin | 2 | 2014 | 203 | 0.530 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 4 | 2014 | 7 | 0.530 |
Why?
|
Cytokines | 2 | 2014 | 243 | 0.520 |
Why?
|
Receptors, GABA-B | 1 | 2015 | 13 | 0.520 |
Why?
|
Neuropharmacology | 1 | 2014 | 3 | 0.510 |
Why?
|
Dermatitis | 1 | 2014 | 20 | 0.500 |
Why?
|
Brain | 4 | 2019 | 930 | 0.490 |
Why?
|
Plant Extracts | 1 | 2014 | 60 | 0.490 |
Why?
|
Cell Movement | 1 | 2015 | 161 | 0.490 |
Why?
|
Cell Line | 9 | 2016 | 449 | 0.490 |
Why?
|
Nicotinic Agonists | 1 | 2014 | 48 | 0.480 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 37 | 0.480 |
Why?
|
Cyclohexanols | 6 | 2016 | 20 | 0.480 |
Why?
|
Glycerides | 3 | 2015 | 13 | 0.480 |
Why?
|
Saliva, Artificial | 1 | 2013 | 2 | 0.470 |
Why?
|
alpha-Amylases | 1 | 2013 | 4 | 0.470 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 3 | 0.460 |
Why?
|
Integrins | 1 | 2013 | 20 | 0.460 |
Why?
|
Rats | 13 | 2014 | 1604 | 0.450 |
Why?
|
Receptors, Opioid, delta | 1 | 2013 | 17 | 0.450 |
Why?
|
Neuroblastoma | 4 | 2017 | 32 | 0.440 |
Why?
|
Humans | 29 | 2019 | 29093 | 0.430 |
Why?
|
Protein Kinases | 1 | 2012 | 28 | 0.430 |
Why?
|
Pertussis Toxin | 6 | 2015 | 16 | 0.420 |
Why?
|
Nicotine | 1 | 2014 | 157 | 0.420 |
Why?
|
Protein Conformation | 5 | 2017 | 85 | 0.400 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 109 | 0.370 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2010 | 89 | 0.360 |
Why?
|
Time Factors | 6 | 2015 | 2001 | 0.350 |
Why?
|
Ligands | 5 | 2011 | 81 | 0.340 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 2 | 2010 | 18 | 0.330 |
Why?
|
Guanylate Cyclase | 2 | 2009 | 6 | 0.330 |
Why?
|
Cyclic GMP | 2 | 2009 | 11 | 0.330 |
Why?
|
Rats, Sprague-Dawley | 7 | 2015 | 747 | 0.330 |
Why?
|
Binding Sites | 4 | 2017 | 125 | 0.320 |
Why?
|
Protein Binding | 5 | 2017 | 199 | 0.310 |
Why?
|
Drama | 1 | 2007 | 1 | 0.310 |
Why?
|
Dexamethasone | 1 | 2007 | 42 | 0.300 |
Why?
|
RNA, Messenger | 6 | 2015 | 514 | 0.300 |
Why?
|
Reactive Nitrogen Species | 1 | 2006 | 5 | 0.290 |
Why?
|
Lipopolysaccharides | 1 | 2006 | 107 | 0.280 |
Why?
|
Cell Membrane | 3 | 2016 | 97 | 0.280 |
Why?
|
Health Education | 1 | 2007 | 121 | 0.280 |
Why?
|
Glucocorticoids | 1 | 2007 | 149 | 0.280 |
Why?
|
Brain Diseases | 1 | 2006 | 40 | 0.280 |
Why?
|
Substance-Related Disorders | 1 | 2007 | 113 | 0.280 |
Why?
|
Receptors, Lysophospholipid | 1 | 2005 | 1 | 0.270 |
Why?
|
Receptors, Eicosanoid | 1 | 2005 | 3 | 0.270 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2005 | 6 | 0.270 |
Why?
|
Kinetics | 4 | 2013 | 205 | 0.270 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 158 | 0.270 |
Why?
|
Terminology as Topic | 1 | 2005 | 62 | 0.260 |
Why?
|
Models, Molecular | 5 | 2017 | 178 | 0.260 |
Why?
|
Macrophages | 1 | 2006 | 188 | 0.260 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 73 | 0.260 |
Why?
|
Analgesics, Opioid | 1 | 2007 | 239 | 0.250 |
Why?
|
Cells, Cultured | 4 | 2015 | 799 | 0.250 |
Why?
|
Amino Acid Sequence | 6 | 2013 | 280 | 0.250 |
Why?
|
Molecular Sequence Data | 6 | 2013 | 350 | 0.240 |
Why?
|
RNA Interference | 2 | 2014 | 76 | 0.240 |
Why?
|
Calcium | 4 | 2015 | 296 | 0.220 |
Why?
|
Protein Transport | 2 | 2016 | 74 | 0.220 |
Why?
|
Rabbits | 3 | 2017 | 185 | 0.220 |
Why?
|
Muscle Relaxation | 1 | 2002 | 7 | 0.220 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2002 | 32 | 0.220 |
Why?
|
Protein Kinase C-alpha | 2 | 2015 | 6 | 0.210 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2002 | 71 | 0.210 |
Why?
|
Zinc | 1 | 2002 | 32 | 0.210 |
Why?
|
Calcium Signaling | 2 | 2015 | 40 | 0.210 |
Why?
|
Aging | 3 | 2015 | 881 | 0.200 |
Why?
|
Marijuana Abuse | 1 | 2019 | 18 | 0.180 |
Why?
|
Reward | 1 | 2019 | 63 | 0.170 |
Why?
|
Male | 12 | 2019 | 17807 | 0.170 |
Why?
|
Receptors, Opioid, mu | 2 | 2010 | 51 | 0.170 |
Why?
|
Blotting, Western | 2 | 2017 | 281 | 0.170 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 248 | 0.160 |
Why?
|
Enzyme Inhibitors | 4 | 2009 | 162 | 0.160 |
Why?
|
Scintillation Counting | 1 | 2017 | 2 | 0.160 |
Why?
|
Sulfur Radioisotopes | 1 | 2017 | 9 | 0.160 |
Why?
|
Alternative Splicing | 1 | 2017 | 28 | 0.150 |
Why?
|
Phylogeny | 1 | 2017 | 58 | 0.150 |
Why?
|
Decision Making | 1 | 2019 | 180 | 0.150 |
Why?
|
Opioid Peptides | 2 | 2008 | 28 | 0.150 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2010 | 37 | 0.150 |
Why?
|
Gene Dosage | 1 | 2016 | 34 | 0.150 |
Why?
|
RGS Proteins | 1 | 2016 | 18 | 0.140 |
Why?
|
Cricetulus | 1 | 2016 | 17 | 0.140 |
Why?
|
CHO Cells | 1 | 2016 | 25 | 0.140 |
Why?
|
Up-Regulation | 2 | 2007 | 183 | 0.140 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 165 | 0.140 |
Why?
|
Cricetinae | 1 | 2016 | 58 | 0.140 |
Why?
|
Calcium Channels | 2 | 2010 | 56 | 0.140 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 72 | 0.140 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 196 | 0.140 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2015 | 1 | 0.130 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2015 | 3 | 0.130 |
Why?
|
Ultrasonics | 1 | 2015 | 6 | 0.130 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2015 | 10 | 0.130 |
Why?
|
Autoradiography | 1 | 2015 | 47 | 0.130 |
Why?
|
Tyrosine | 1 | 2015 | 22 | 0.130 |
Why?
|
Solitary Nucleus | 1 | 2015 | 34 | 0.130 |
Why?
|
Hippocampus | 2 | 2015 | 185 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 37 | 0.130 |
Why?
|
History, 19th Century | 1 | 2014 | 17 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 44 | 0.130 |
Why?
|
Central Nervous System | 1 | 2014 | 29 | 0.130 |
Why?
|
History, 21st Century | 1 | 2014 | 48 | 0.130 |
Why?
|
Genes, Immediate-Early | 1 | 2014 | 2 | 0.130 |
Why?
|
History, 20th Century | 1 | 2014 | 68 | 0.130 |
Why?
|
Uterine Artery | 1 | 2014 | 4 | 0.130 |
Why?
|
Superoxides | 1 | 2014 | 17 | 0.130 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2014 | 10 | 0.120 |
Why?
|
Random Allocation | 1 | 2015 | 213 | 0.120 |
Why?
|
Pregnancy, Animal | 1 | 2014 | 19 | 0.120 |
Why?
|
Baroreflex | 1 | 2015 | 84 | 0.120 |
Why?
|
Vasoconstriction | 1 | 2014 | 40 | 0.120 |
Why?
|
Autoreceptors | 1 | 2014 | 9 | 0.120 |
Why?
|
Monoacylglycerol Lipases | 1 | 2013 | 5 | 0.120 |
Why?
|
Thermodynamics | 2 | 2004 | 45 | 0.120 |
Why?
|
Amphetamine | 1 | 2014 | 36 | 0.120 |
Why?
|
Wound Healing | 1 | 2015 | 182 | 0.120 |
Why?
|
Inflammation Mediators | 1 | 2014 | 101 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 1218 | 0.120 |
Why?
|
Urodynamics | 1 | 2013 | 34 | 0.120 |
Why?
|
Interleukin-1alpha | 1 | 2013 | 2 | 0.120 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2013 | 17 | 0.120 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2013 | 7 | 0.120 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2013 | 8 | 0.120 |
Why?
|
Interleukin-8 | 1 | 2013 | 23 | 0.120 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2013 | 18 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 22 | 0.120 |
Why?
|
Laminin | 1 | 2013 | 13 | 0.120 |
Why?
|
src-Family Kinases | 1 | 2013 | 16 | 0.120 |
Why?
|
Culture Media | 1 | 2013 | 39 | 0.110 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2013 | 3 | 0.110 |
Why?
|
Nucleus Accumbens | 2 | 2014 | 92 | 0.110 |
Why?
|
Fibronectins | 1 | 2013 | 34 | 0.110 |
Why?
|
Muscle, Smooth | 1 | 2013 | 73 | 0.110 |
Why?
|
Oligopeptides | 1 | 2013 | 51 | 0.110 |
Why?
|
Muscle Contraction | 1 | 2013 | 114 | 0.110 |
Why?
|
Structure-Activity Relationship | 2 | 2003 | 82 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2014 | 223 | 0.110 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2014 | 120 | 0.110 |
Why?
|
Angiotensin II | 1 | 2014 | 279 | 0.110 |
Why?
|
Ultrasonography | 1 | 2015 | 345 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2013 | 225 | 0.110 |
Why?
|
Transcriptional Activation | 1 | 2012 | 42 | 0.110 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 200 | 0.110 |
Why?
|
Urinary Bladder | 1 | 2013 | 164 | 0.100 |
Why?
|
Prosencephalon | 2 | 2012 | 5 | 0.100 |
Why?
|
Dopamine | 1 | 2014 | 226 | 0.100 |
Why?
|
Cysteine | 1 | 2012 | 131 | 0.100 |
Why?
|
Hydrogen Bonding | 2 | 2017 | 18 | 0.100 |
Why?
|
Protein Structure, Secondary | 2 | 2007 | 45 | 0.100 |
Why?
|
Sucrose | 1 | 2010 | 17 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2007 | 95 | 0.090 |
Why?
|
Computer Simulation | 2 | 2017 | 207 | 0.090 |
Why?
|
Adaptor Protein Complex 3 | 1 | 2010 | 2 | 0.090 |
Why?
|
Arrestins | 1 | 2010 | 3 | 0.090 |
Why?
|
Receptors, Dopamine D4 | 2 | 2008 | 6 | 0.090 |
Why?
|
Vesicular Transport Proteins | 1 | 2010 | 10 | 0.090 |
Why?
|
Eating | 1 | 2010 | 73 | 0.090 |
Why?
|
Dietary Fats | 1 | 2010 | 108 | 0.090 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2009 | 17 | 0.090 |
Why?
|
Receptors, Dopamine | 1 | 2008 | 20 | 0.080 |
Why?
|
Neostriatum | 1 | 2008 | 21 | 0.080 |
Why?
|
Receptors, Opioid | 1 | 2008 | 38 | 0.080 |
Why?
|
Leucine | 1 | 2007 | 24 | 0.080 |
Why?
|
Drug Synergism | 1 | 2007 | 67 | 0.080 |
Why?
|
Static Electricity | 1 | 2007 | 11 | 0.080 |
Why?
|
Drug Interactions | 1 | 2007 | 80 | 0.080 |
Why?
|
Cell Division | 1 | 2007 | 97 | 0.080 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 18 | 0.080 |
Why?
|
Cytoplasm | 1 | 2007 | 30 | 0.080 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2007 | 10 | 0.080 |
Why?
|
Parent-Child Relations | 1 | 2007 | 38 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 155 | 0.070 |
Why?
|
Young Adult | 2 | 2019 | 2402 | 0.070 |
Why?
|
Cycloheximide | 1 | 2006 | 7 | 0.070 |
Why?
|
Genomics | 1 | 2007 | 82 | 0.070 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2006 | 12 | 0.070 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 18 | 0.070 |
Why?
|
Focus Groups | 1 | 2007 | 103 | 0.070 |
Why?
|
Neuronal Plasticity | 1 | 2007 | 81 | 0.070 |
Why?
|
Peptides | 1 | 2007 | 118 | 0.070 |
Why?
|
Risk-Taking | 1 | 2007 | 91 | 0.070 |
Why?
|
Ganglia, Spinal | 1 | 2007 | 63 | 0.070 |
Why?
|
Program Evaluation | 1 | 2007 | 175 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 130 | 0.070 |
Why?
|
Microglia | 1 | 2006 | 48 | 0.070 |
Why?
|
Crystallography, X-Ray | 1 | 2006 | 77 | 0.070 |
Why?
|
Adolescent | 2 | 2019 | 3254 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2007 | 179 | 0.070 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2005 | 15 | 0.070 |
Why?
|
Mutation | 2 | 2012 | 466 | 0.070 |
Why?
|
Membrane Proteins | 1 | 2006 | 256 | 0.060 |
Why?
|
Molecular Conformation | 1 | 2004 | 8 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2007 | 641 | 0.060 |
Why?
|
Mice, Knockout | 3 | 2013 | 425 | 0.060 |
Why?
|
Cannabis | 1 | 2004 | 18 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 326 | 0.060 |
Why?
|
Research | 1 | 2004 | 72 | 0.060 |
Why?
|
Sequence Homology | 1 | 2003 | 3 | 0.060 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 4 | 0.060 |
Why?
|
Cattle | 1 | 2003 | 100 | 0.060 |
Why?
|
North Carolina | 1 | 2007 | 1423 | 0.060 |
Why?
|
Eicosanoids | 1 | 2002 | 7 | 0.060 |
Why?
|
Receptors, Calcitonin Gene-Related Peptide | 1 | 2002 | 2 | 0.050 |
Why?
|
Virulence Factors, Bordetella | 1 | 2002 | 9 | 0.050 |
Why?
|
Nervous System | 1 | 2002 | 15 | 0.050 |
Why?
|
Gap Junctions | 1 | 2002 | 2 | 0.050 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2002 | 18 | 0.050 |
Why?
|
Models, Chemical | 1 | 2002 | 30 | 0.050 |
Why?
|
Capsaicin | 1 | 2002 | 30 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 36 | 0.050 |
Why?
|
Protons | 1 | 2002 | 23 | 0.050 |
Why?
|
Zinc Compounds | 1 | 2002 | 4 | 0.050 |
Why?
|
Chlorides | 1 | 2002 | 15 | 0.050 |
Why?
|
Magnesium | 1 | 2002 | 22 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2002 | 56 | 0.050 |
Why?
|
Aorta | 1 | 2002 | 103 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 158 | 0.050 |
Why?
|
Software | 1 | 2002 | 109 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2002 | 248 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 145 | 0.050 |
Why?
|
Receptors, Dopamine D3 | 2 | 2014 | 33 | 0.050 |
Why?
|
Adult | 2 | 2019 | 8420 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 711 | 0.050 |
Why?
|
Resorcinols | 2 | 2013 | 6 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2002 | 436 | 0.050 |
Why?
|
Blood Pressure | 2 | 2015 | 804 | 0.050 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 71 | 0.040 |
Why?
|
Algorithms | 1 | 2002 | 462 | 0.040 |
Why?
|
Clathrin | 1 | 2016 | 3 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2016 | 4 | 0.040 |
Why?
|
Female | 4 | 2019 | 18164 | 0.040 |
Why?
|
Endosomes | 1 | 2016 | 13 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 36 | 0.040 |
Why?
|
Microinjections | 1 | 2015 | 33 | 0.030 |
Why?
|
Radioligand Assay | 1 | 2015 | 23 | 0.030 |
Why?
|
Sensory Receptor Cells | 1 | 2015 | 29 | 0.030 |
Why?
|
Cerebellum | 1 | 2015 | 29 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2015 | 99 | 0.030 |
Why?
|
Monoglycerides | 1 | 2014 | 2 | 0.030 |
Why?
|
Benzodioxoles | 1 | 2014 | 6 | 0.030 |
Why?
|
Amidohydrolases | 1 | 2014 | 8 | 0.030 |
Why?
|
Hydrolysis | 1 | 2014 | 38 | 0.030 |
Why?
|
Carbamates | 1 | 2014 | 14 | 0.030 |
Why?
|
Rats, Transgenic | 1 | 2014 | 52 | 0.030 |
Why?
|
Benzamides | 1 | 2014 | 54 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2013 | 63 | 0.030 |
Why?
|
Cholinergic Agonists | 1 | 2013 | 3 | 0.030 |
Why?
|
Carbachol | 1 | 2013 | 7 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 2013 | 30 | 0.030 |
Why?
|
Oxotremorine | 1 | 2013 | 3 | 0.030 |
Why?
|
Spatial Behavior | 1 | 2013 | 9 | 0.030 |
Why?
|
Muscarinic Agonists | 1 | 2013 | 7 | 0.030 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2013 | 15 | 0.030 |
Why?
|
Indoles | 1 | 2013 | 58 | 0.030 |
Why?
|
Glycine | 1 | 2013 | 25 | 0.030 |
Why?
|
Heart Rate | 1 | 2015 | 315 | 0.030 |
Why?
|
Fatty Acids | 1 | 2013 | 92 | 0.030 |
Why?
|
Electric Stimulation | 1 | 2013 | 102 | 0.030 |
Why?
|
CA1 Region, Hippocampal | 1 | 2013 | 26 | 0.030 |
Why?
|
Self Administration | 1 | 2014 | 296 | 0.030 |
Why?
|
Lipoylation | 1 | 2012 | 3 | 0.030 |
Why?
|
Learning | 1 | 2013 | 76 | 0.030 |
Why?
|
Age Factors | 1 | 2015 | 1108 | 0.030 |
Why?
|
Pregnancy | 1 | 2014 | 815 | 0.020 |
Why?
|
Sweetening Agents | 1 | 2010 | 8 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2014 | 980 | 0.020 |
Why?
|
Liver | 1 | 2013 | 464 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2009 | 126 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2010 | 159 | 0.020 |
Why?
|
Receptors, Dopamine D5 | 1 | 2008 | 2 | 0.020 |
Why?
|
Receptors, Dopamine D1 | 1 | 2008 | 19 | 0.020 |
Why?
|
Lipid Bilayers | 1 | 2007 | 6 | 0.020 |
Why?
|
Mutagenesis | 1 | 2007 | 32 | 0.020 |
Why?
|
Benzofurans | 1 | 2007 | 5 | 0.020 |
Why?
|
Chromones | 1 | 2007 | 6 | 0.020 |
Why?
|
Enzyme Activators | 1 | 2007 | 4 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2007 | 12 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2008 | 167 | 0.020 |
Why?
|
Aniline Compounds | 1 | 2007 | 25 | 0.020 |
Why?
|
Gadolinium | 1 | 2007 | 18 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2007 | 69 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2007 | 77 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 97 | 0.020 |
Why?
|
Transfection | 1 | 2007 | 192 | 0.020 |
Why?
|
Enkephalins | 1 | 2006 | 9 | 0.020 |
Why?
|
Dynorphins | 1 | 2006 | 9 | 0.020 |
Why?
|
Protein Precursors | 1 | 2006 | 22 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 1063 | 0.020 |
Why?
|
Analgesics | 1 | 2007 | 126 | 0.020 |
Why?
|